Most Read Articles
Stephen Padilla, 4 days ago
The novel coronavirus disease (COVID-19) pandemic appears to have a significant impact on oncological care, according to a study, which stresses the need for psycho-oncological support for cancer patients.
01 Aug 2020
Supplementation with probiotics may have positive effects in patients with type 2 diabetes mellitus (T2DM), reports a recent meta-analysis.
Roshini Claire Anthony, 30 Jul 2020

Frailty may indicate an increased risk of death from COVID-19, results of the COPE* study showed.

03 Aug 2020
Treatment with tradipitant in patients with idiopathic or diabetic gastroparesis produces meaningful improvements in nausea and vomiting, according to the results of a phase II trial.

HbA1c grading tied to drug resistance in TB patients with T2DM

04 Jun 2020

HbA1c grading influences the risk of developing isoniazid resistance and multidrug resistance (MDR) in tuberculosis (TB) infected patients with type 2 diabetes mellitus (T2DM), a study suggests.

Researchers reviewed relevant studies to pool existing evidence, conducted a multicentre retrospective clinical study to identify the impact of HbA1c on the development of anti-TB drug resistance, and developed a model to accurately predict and individually assess the development of MDR for TB–T2DM patients.

Results for the systematic review were inconsistent. Meanwhile, the multicentre chart review with 657 records consisted of 390 patients with HbA1c <7 percent and 267 with HbA1c ≥7 percent.

Patients in the HbA1c <7 percent group had a lower risk of developing rifampicin resistance (odds ratio [OR], 1.904; p=0.001), isoniazid resistance (OR, 2.896; p<0.001), and MDR (ORs, 3.228; p<0.001).

The model for MDR that included HbA1c grading demonstrated excellent predictive ability, with an area under the curve (AUC) of 75.4 percent in training set and 73.9 percent in internal validation set. The addition of HbA1c grading also significantly improved the model performance in calibration, prediction probabilities, and net clinical benefit.

There are several ways that HbA1c can induce anti-TB drug resistance. First is through the involvement of oxidative stress, which plays a crucial role in activation of resistance to isoniazid. Furthermore, hyperglycaemia may reduce the concentration of isoniazid in blood by delaying absorption and promoting elimination, with lower drug concentrations contributing to the development of drug resistance to a great degree. [Eur J Clin Pharmacol 2017;73:65-70; ACS Omega 2018;3:4213-4219; J Biol Chem 2018;293:17200-17207]

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Stephen Padilla, 4 days ago
The novel coronavirus disease (COVID-19) pandemic appears to have a significant impact on oncological care, according to a study, which stresses the need for psycho-oncological support for cancer patients.
01 Aug 2020
Supplementation with probiotics may have positive effects in patients with type 2 diabetes mellitus (T2DM), reports a recent meta-analysis.
Roshini Claire Anthony, 30 Jul 2020

Frailty may indicate an increased risk of death from COVID-19, results of the COPE* study showed.

03 Aug 2020
Treatment with tradipitant in patients with idiopathic or diabetic gastroparesis produces meaningful improvements in nausea and vomiting, according to the results of a phase II trial.